Clinical Trial Update: Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial. [Phase 1, Phase 2]

View source ↗

Summary

This document outlines an ongoing single-arm, open-label Phase 1/2 trial assessing the safety and efficacy of CAR-T cell therapy in relapsed/refractory neurobla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Neuroblastoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Sun Yat-Sen University Cancer Center | Conditions: Neuroblastoma (NB), Desmoplastic Small Round Cell Tumor (DSRCT) | Phase 1, Phase 2 | Status: RECRUITING